Investigational therapies for non-muscle invasive bladder cancer. - Wikidata - awgldk - TriplyDB

Investigational therapies for non-muscle invasive bladder cancer.

Investigational therapies for non-muscle invasive bladder cancer.

http://www.wikidata.org/entity/Q37676223

about

RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancer Surveillance and treatment of non-muscle-invasive bladder cancer in the USA.Emerging intravesical therapies for management of nonmuscle invasive bladder cancer Future directions in bladder cancer immunotherapy: towards adaptive immunity.

P2860

Q34994521-3CD45EB1-F404-4183-8F7A-48BB102D8FF6 Q35977496-7008BC6B-F0E2-46D3-8EBC-73F45B24D8F3 Q37283563-47499344-A254-4DE8-9FC2-FA5B22FFD9EA Q38727522-1E814170-A908-490D-A16C-37EA15F32DE0

P2860

Investigational therapies for non-muscle invasive bladder cancer.

http://www.wikidata.org/entity/Q37676223

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Investigational therapies for non-muscle invasive bladder cancer.

@en

Investigational therapies for non-muscle invasive bladder cancer.

@nl

type

label

Investigational therapies for non-muscle invasive bladder cancer.

@en

Investigational therapies for non-muscle invasive bladder cancer.

@nl

prefLabel

Investigational therapies for non-muscle invasive bladder cancer.

@en

Investigational therapies for non-muscle invasive bladder cancer.

@nl

P1433

Q37676223-6717419B-2659-438E-818D-487999757353

P1476

Q37676223-FF52F14B-37DD-4B48-9280-1C68EC87EF65

P2093

Q37676223-18D46528-9CAF-46F5-A475-BA1707643BA4

Q37676223-1AD762B0-01C7-4D80-B6BD-829DD31633F1

Q37676223-55306369-E9FF-4D8B-99AE-7531CC0E9EAC

Q37676223-B7C113A5-CDC5-4A4A-8984-DE9AF545B30E

P2860

Q37676223-06F378D0-E530-476B-B30B-B661BC20B421

Q37676223-074035F9-1264-43F2-9469-51F0D3D06967

Q37676223-094EA83B-3F67-42AE-9E47-167ACC0CB33E

Q37676223-0A036483-8A2A-4C6D-A10D-C38A513CC971

Q37676223-133D25EE-EAE8-4A4D-B28F-AE9E11A56E30

Q37676223-171A4760-75B3-4833-AB2D-1AAFF029D719

Q37676223-1860AEA8-99C2-4DE9-B434-5FDAD0A86D77

Q37676223-1944A020-24E1-47B7-800A-2AD670E6B45A

Q37676223-1D280D98-827C-4626-B2F2-EA0D9BE45DFC

Q37676223-1FABF29B-6A0D-45DC-A421-E933DF1A57DB

P304

Q37676223-906E2E74-2F93-4C6D-80A4-48B4122218D6

P31

Q37676223-D204983E-0F99-4EDA-9C9E-75A53048B3EB

P356

Q37676223-99F29085-FC13-43FD-A5A1-E3B161E4D46F

P407

Q37676223-67150FED-5A98-4E68-9FA3-FA4590D7B801

P433

Q37676223-81998CC0-12A9-42E4-8206-94B5EE6AA73B

P478

Q37676223-003961B6-B20A-4F2F-BDD6-B25D0EED47A0

P577

Q37676223-C8B4D725-A105-45C9-88CD-74A51970167F

P698

Q37676223-B72F8010-9808-4C01-860E-B7FABA1D2B67

P356

13543780903563372

P1433

Expert Opinion on Investigational Drugs

P1476

Investigational therapies for non-muscle invasive bladder cancer.

@en

P2093

Daniel P Casella

http://www.w3.org/2001/XMLSchema#string

Daniel R Welchons

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Gingrich

http://www.w3.org/2001/XMLSchema#string

Marc C Smaldone

http://www.w3.org/2001/XMLSchema#string

P2860

Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion

Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study.

Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma

Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.

Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma.

Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract.

Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results.

Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.

P304

371-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543780903563372

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20078248

http://www.w3.org/2001/XMLSchema#string